Historical review reveals advancements in oxygen therapy for chronic hypoxemia, suggesting future improvements in device portability.
The story of the development of oxygen and its role in mitigating the ravages of chronic stable hypoxemia have been fascinating. Today, over one million Americans receive home oxygen each day, usually for COPD, from one of the three available systems. The future requires less expensive, highly portable, and practical devices for use during all activities of daily living.
No takes yet. Share an insight, caveat, or question.
T L Petty (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: